Table 3 Treatment and outcome of patients with cholelithiasis
From: Effect of statin use on outcome of symptomatic cholelithiasis: a case-control study
Statin use (n = 272) | No statin (n = 272) | p-value | |
|---|---|---|---|
Overall mortality | 12 (4%) | 19 (7%) | 0.195 |
ICU treatment (N patients) | 6 (2%) | 3 (1%) | 0.348 |
Mean hospital stay, days | 4.3 ± 9.9 | 3.9 ± 4.7 | 0.7301 |
Treatment type | |||
Conservative/Surgical | 73/199 (27/73%) | 68/204 (25/75%) | 0.625 |
Elective/emergency operation | 138/61 (69/31%) | 136/68 (67/33%) | 0.769 |
Laparoscopic | 131 (65%) | 130 (64%) | 0.659 |
Open surgery | 47 (24%) | 46 (23%) | 0.799 |
Conversion | 13 (7%) | 17 (8%) | 0.491 |
Cholecystostoma | 8 (4%) | 11 (5%) | 0.516 |
Reoperations | 6 (3.0%) | 3 (1.5%) | 0.211 |
Choledochotomy | 13 (7%) | 20 (10%) | 0.197 |
Choledocholithiasis | 9 (5%) | 20 (10%) | 0.104 |
Complications (operated) | 27 (13.6%) | 32 (15.7%) | 0.733 |
Urological | 5 (2.5%) | 7 (3.4%) | |
Peritonitis | 3 (1.5%) | 3 (1.5%) | |
Bleeding | 4 (2.0%) | 3 (1.5%) | |
Bile leak | 3 (1.5%) | 1 (0.5%) | |
Other abscess | 1 (0.5%) | 1 (0.5%) | |
Heart complication | 1 (0.5%) | 1 (0.5%) | |
Lung complication | 1 (0.5%) | 0 | |
Other | 9 (4.5%) | 16 (7.8%) | |
ERCP (all) | 31 (11%) | 34 (13%) | 0.595 |